Pembrolizumab and Nab Paclitaxel in Patients With Metastatic Urothelial Carcinoma

NCT03464734 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Urothelial Carcinoma

Interventions

DRUG: Pembrolizumab and Nanoparticle Albumin-bound Paclitaxel

Sponsor

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano